TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$44.12
+2.00 (+4.75%)
Performance
1D
—
1W
—
1M
—
3M
+46.72%
6M
+28.33%
1Y
+120.38%
YTD
+11.64%
Open$42.52
Previous Close$42.12
Day High$44.70
Day Low$42.09
52W High$48.61
52W Low$13.88
Volume—
Avg Volume2.87M
Market Cap3.97B
P/E Ratio—
EPS$-0.33
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.84
Above
SMA 200
$24.79
Above
RSI (14)
40.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-15.8% upside
Current
$44.12
$44.12
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 494.60M | 373.90M | 873.79M |
| Net Income | -25,751,833 | -17,520,902 | 83.63M |
| Profit Margin | -5.2% | -5.0% | 9.6% |
| EBITDA | 7.72M | 5.55M | 111.75M |
| Free Cash Flow | — | — | 68.75M |
| Rev Growth | +32.3% | +32.3% | +12.5% |
| Debt/Equity | 2.71 | 2.71 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |